Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 29, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 29, 2025 -- For U.S. adult cancer survivors with a new alcohol use disorder (AUD) diagnosis, the one-year cumulative incidence of AUD treatment initiation was 14.3 percent, according to a research letter published online May 27 in the Annals of Internal Medicine.

Anton L.V. Avanceña, Ph.D., from The University of Texas at Austin, and colleagues estimated the cumulative incidence of U.S. Food and Drug Administration-approved medications for AUDs (MAUDs) and initiation of psychosocial therapy among cancer survivors in a retrospective cohort study using Merative MarketScan claims data from January 2011 to December 2021. The sample was limited to cancer survivors with a new AUD diagnosis.

Data were included for 71,875 cancer survivors who received an AUD diagnosis. The researchers found that the one-year cumulative incidence of AUD treatment initiation was 14.3 percent. The one-year cumulative incidence of psychosocial therapy initiation was 12.6 percent, while the cumulative incidence of U.S. Food and Drug Administration-approved MAUD initiation was 2.8 percent. Within a year after AUD diagnosis, only 0.95 percent of cancer survivors received both FDA-approved MAUD and psychosocial therapy. Compared with male cancer survivors, female cancer survivors had a higher one-year cumulative incidence of AUD treatment initiation (18.2 versus 12.2 percent). Incidence was also higher for cancer survivors aged younger than 65 years versus those aged 65 years or older (17.2 versus 8.3 percent).

"Low rates of AUD treatment may be influenced by system-level factors like low provider knowledge about MAUDs as well as patient-level factors, including beliefs that AUD will resolve on its own and stigma associated with AUD," the authors write.

Abstract/Full Text (subscription or payment may be required

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-30 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords